M K Proteins: Un-Audited Standalone Financial Results of the Company for the Quarter and half year ended September 30,…
M K Proteins (MKPL) filed a disclosure titled "Un-Audited Standalone Financial Results of the Company for the Quarter and half year ended September 30, 2026, together with a Statement of Cash Flow, Statement of Assets and…". The company is valued at about…
What happened
M K Proteins (MKPL) filed a disclosure with the exchanges on 13 November 2026 at 04:25 PM titled "Un-Audited Standalone Financial Results of the Company for the Quarter and half year ended September 30, 2026, together with a Statement of Cash Flow, Statement of Assets and…".
From the filing: "M K Proteins Limited has submitted to the Exchange, Un-Audited Standalone Financial Results of the Company for the Quarter and half year ended September 30, 2026, together with a Statement of Cash Flow, Statement of Assets and Liabilities for the same period"
Company snapshot
M K Proteins is a micro-cap company, with a market value of about ₹150 crore.
The stock last traded at ₹4, against a 52-week range of ₹3.5–₹6.92 (42.2% below the high).
Before this filing the shares had moved +2.3% over the month and −4.5% over three months. Average daily turnover over the last 20 sessions was about ₹0.04 crore.
Promoters held 74.82% at the end of Q1 FY27.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 115 | 3.5 | 0.09 |
| Q2 FY26 | 32 | 0.7 | 0.02 |
| Q3 FY26 | 90 | 1.4 | 0.04 |
| Q4 FY26 | 146 | 1.1 | 0.03 |
| Q1 FY27 | 115 | 1.4 | 0.04 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock fell 1.3% on average the next trading day and was down 1.8% on average after five days (2 filings with price data).
Market-wide, 11,743 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 13 Aug 2026 | , the financial results for the period ended Jun 30, 2026 approvaed… | −1.4% | −1.0% |
| 29 May 2026 | Audited Standalone Financial Results Of The Company For The Quarter… | −1.2% | −2.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 13 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.